After optimization of the reaction conditions, action of nucleophiles on the tosyl derivatives of 4-hydroxymethyl oxazolines 1 and 2 afforded precursors of alpha and beta aminoacids.
After optimization of the reaction conditions, action of nucleophiles on the tosyl derivatives of 4-hydroxymethyl oxazolines 1 and 2 afforded precursors of alpha and beta aminoacids.
Synthesis of Optically Active Oxazoline Derivatives via Catalytic Asymmetric Desymmetrization of 1,3-Diols
作者:Yutaro Tsuda、Masami Kuriyama、Osamu Onomura
DOI:10.1002/chem.201103800
日期:2012.2.27
oxazolines: A synthetic method to prepare optically active oxazolines through a copper‐catalyzed asymmetric desymmetrization of 1,3‐diols has been successfully developed. This reaction system tolerated a diverse range of substrates to give the desired oxazoline derivatives in good to excellent yields with high enantioselectivities (see scheme).
Simple and Efficient Synthesis of Racemic 2-(tert-Butoxycarbon-ylamino)-2-methyl-3-(1H-1,2,4-triazol-1-yl)propanoic Acid, a New Derivative of β-(1,2,4-Triazol-1-yl)alanine
A simple synthetic approach to racemic N-tert-butyloxycarbonyl-2-methyl-3-(1H-1,2,4-triazol-1-yl)alanine (5) in four steps and 68% overall yield starting from oxazoline derivative 1 is reported. This synthesis involves the alkylation of 1H-1,2,4-triazole with an O-tosyloxazoline derivative, followed by an oxazoline ring-opening reaction and oxidation of the N-protected β‑aminoalcohol by potassium permanganate
METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND OR SALT THEREOF
申请人:Onomura Osamu
公开号:US20140012010A1
公开(公告)日:2014-01-09
Provided is a process for producing an optically active compound represented by Formula (3):
(wherein R
1
is an alkyl group, an alkynyl group, an alkenyl group, an aliphatic heterocyclic group, a cycloalkyl group, an aryl group, an aralkyl group, or an aromatic heterocyclic group, and any hydrogen atom of R
1
may be replaced with a substituent; R
2
is a hydrogen atom or a group which is not reactive in the reaction below; and * represents a chiral center) or a salt thereof by subjecting a compound represented by Formula (1):
(wherein R
1
and R
2
have the same meanings as defined in Formula (3)) to a ring closure reaction in the presence of a chiral ligand having 1 or more coordination sites, a Lewis acid represented by Formula (2):
M
m
Z
n
(2)
(wherein M is a metal ion, Z is a counter anion of M, and m and n are integers of 1 to 4), and a sulfonyl halide having an optionally substituted alkyl or phenyl group